Latest Industry Insights

In this article, Cristiana Bercea discusses how large, automated storage solutions are helping companies to save time, unlock greater efficiency and better meet sustainability goals – without increasing risk.

We spoke with Dr. Michael Gonzales to learn more about the UKB-PPP and its goals, the technical hurdles of large-scale proteomics and how Olink technology is helping to overcome them.

Dr. Bo Wiinberg, chief business development officer at the Novo Nordisk Foundation Cellerator, discusses the current obstacles halting advances in stem cell-based cell therapies and what can be done to overcome them.

bit.bio’s GFP ioMicroglia enables real-time tracking of microglia in complex co-cultures and in vivo, streamlining neurodegeneration research and drug discovery.

Technology Networks spoke with Dr. Richard Cuthbert, cell biology product manager at Bio-Rad, to learn more about Bio-Rad's new ZE5 Cell Analyzer, the challenges within the field and recent technological advancements in flow cytometry.

Gilberto Barcellos and Dr. Melanie Bailey discuss the growing interest in single-cell lipidomics, the key challenges researchers face and how the SS2000 is helping to overcome these hurdles.

In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's custom antibody services team, to learn more about the developments and future directions within antibody innovation.

In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both scientific and technological progress.

In this interview, Technology Networks spoke with Dr. Laura Lyon, product manager of cell culture technologies at Sartorius, to explore the critical role of cytokines and growth factors in in vitro experiments.

Dr. Emanuela Costigliola discusses recent advances in preclinical drug development and the significance of physiologically relevant models in predicting human responses.